A Phase 1 Study of AJ302-IM in Healthy Volunteers
Completed Phase 1 NCT06625541
Study Description
A Study to Evaluate the Safety and Effects of an Investigational Drug (AJ302-IM) in Healthy People
Study Details
- Registry ID:
- NCT06625541
- Conditions:
- Healthy Volunteers
- Phase:
- Phase 1
- Target Enrollment:
- 57 participants
- Start Date:
- Age Range:
- 18–55 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
AnnJi Investigational Site
Miami, Florida, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.